Weikai Xiao
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 7
- Breast Cancer Treatment Studies 6
- Cancer, Lipids, and Metabolism 4
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 4
- Cancer Cells and Metastasis 4
-
- Lung Cancer Treatments and Mutations 6
- Advanced Breast Cancer Therapies 4
- Co-authors
- Yutian ZouShaoquan ZhengBaogang PengAnli YangShaoqiang LiShunjun FuHailin TangLi‐Jian Liang
- Cited by
- Cancer ResearchHepatologyOncology
- Journals
- Journal of Clinical Oncology (2 papers)Scientific Reports (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Weikai Xiao
37 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 82
- Cancer Research 473
- Hepatology 213
- Oncology 477
- Pulmonary and Respiratory Medicine 265
- Molecular Biology 425
Countries citing papers authored by Weikai Xiao
This map shows the geographic impact of Weikai Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weikai Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weikai Xiao more than expected).
Fields of papers citing papers by Weikai Xiao
This network shows the impact of papers produced by Weikai Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weikai Xiao. The network helps show where Weikai Xiao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weikai Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 28 | |
| 2 | 2023 | 42 | |
| 3 | 2022 | 9 | |
| 4 | 2021 | 5 | |
| 5 | 2021 | 18 | |
| 6 | 2021 | 2 | |
| 7 | 2021 | 5 | |
| 8 | 2021 | 28 | |
| 9 | 2020 | 9 | |
| 10 | 2018 | 121 | |
| 11 | 2018 | 67 | |
| 12 | 2018 | 5 | |
| 13 | 2018 | 36 | |
| 14 | 2016 | 33 | |
| 15 | 2014 | 1 | |
| 16 | 2014 | 189 | |
| 17 | 2014 | 39 | |
| 18 | 2013 | 72 | |
| 19 | 2013 | 28 | |
| 20 | Expression of Claudins in the Normal Adult Human Retinas | 2010 | 1 |
About Weikai Xiao
Weikai Xiao is a scholar working on Cancer Research, Hepatology and Oncology, having authored 37 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer Genomics and Diagnostics (7 papers), Breast Cancer Treatment Studies (6 papers), Lung Cancer Treatments and Mutations (6 papers), Advanced Breast Cancer Therapies (4 papers), Cancer, Lipids, and Metabolism (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Cells and Metastasis (4 papers). The work is most often cited by research in Cancer Research (473 citations), Hepatology (213 citations) and Oncology (477 citations). Weikai Xiao has collaborated with scholars based in China and United States. Frequent co-authors include Yutian Zou, Shaoquan Zheng, Baogang Peng, Anli Yang, Shaoqiang Li, Shunjun Fu, Hailin Tang, Li‐Jian Liang, Xiaoming Xie and Dong Chen. Their work appears in journals such as Journal of Clinical Oncology, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.